Photo of Litigation Blog Mitchell P. Morinec mmorinec@smsm.com
312.645.7813
Mitch Morinec is a shareholder in the Chicago office of Segal McCambridge Singer & Mahoney and serves as Chair of the firm's Life Sciences Practice Group. Mr. Morinec …

Showing 1 post by Mitchell P. Morinec.

LIFE SCIENCES CLIENT ALERT: United States Supreme Court holds that the judge, not the jury, makes pre-emption determination in failure-to-warn pharmaceutical cases.

It is the role of the district judge—not the jury—to determine if the FDA would have approved a drug’s warning label that state law requires when deciding whether a failure-to-warn claim is pre-empted, the United States Supreme Court held on Monday. The unanimous decision provides clarity to the high court’s “clear evidence” standard it introduced over a decade ago in Wyeth v. Levine, and resolves a split between the circuit courts in how to apply the standard. More »

Get Updates By Email

Blog Contributors